yeah, just look at me. >>> swranity fair's new issue has a deep dive on theranos.ick builten recounts the damage control that it went, including rushing into an interview with our ven own jim cramer. >> this is what happens when you work to change things and first they think you're crazy, then they fight you, and then all of a sudden you change the world. >> or not. nick billton joins us now. thanks for being with us. one of the things that struck me about this is her professors even early on are arguing against the efficacy of the method that she was trying to use to analyze blood, and she stiff is kind of hanging on to her story even now itches what did that tell you about her character, her special. >> interesting, when i first started reporting this piece, i thought it was being to be a lay of the land of what happened and how things erupted aft the "wall street journal" published a large piece on theranos not being what it said it was. the more i spoke to people, the more interviews i did, the more my mouth was agape at what i heard. i spoke to a professor who

we began with his thoughts on theranos. testing startup drew application for a diagnostic blood test for the zika virus , after regulators found problems with the way theranos was gathering patient data. this coming after u.s. regulators sanctioned theranos. this is for failing to run laps up to standards. we asked his thoughts on the beleaguered startup. take a listen. you have been investing in the space longer than newer investors. i wonder if you seen anything like this? stephen: it is amazing. for someone who cares deeply about putting products and services in the hands of patients and doctors, it is pretty maddening. anyone who is serious as a -- health care investor and entrepreneur enough is enough. , the company had to pull back test results. their ceo has been banned from operating in a lab. they have had partners leave them. now this zika result proves they did not operate the clinical trial well. it is frustrating. it overshadows a lot of the great work that is happening in health care. emily: did she pitch to y

theranos was burned. emily: where do you see potential?re a lot of newer investors getting into the space. you have been doing this a long time. stephen: it is a great time in health care. his industry that, for too long, -- this is an industry that, for too long, it has been pretty archaic and behind other modern industries in terms of technology. i think we are in the 1990's of enterprise software in health care. only five years ago, 50% of doctors did not use software to capture your clinical information. that is shocking. emily: pretty sure my doctor still writes on a notepad. [laughter] stephen: that is a problem and that is changing. emily: i like her. stephen: you like her, but your data is nowhere. if you want to manage a population's health, and you don't have that information, you cannot really change health care for the better or lower costs or improve quality. that is where we are sitting today. you have 100% of doctors using digital health records. now you can do things happening in other industries like complex data analytics

this came after the sanctioned theranos. take a listen.e been investing in the space longer than newer investors. i wonder if you seen anything like this? >> it is amazing. for someone who cares deeply about putting products and services in the hands of patients and doctors, it is maddening. anyone who is serious as a health care investor, another is enough. the company had to pull back test results. they have had partners leave them. another zika result proves they do not operate the clinical trial well. it is frustrating. it overshadows a lot of the great work that is happening in health care. if you talk to most helped investors, she did not pitch to anyone who had health care experience. it is a complex industry where you think you would want folks who have health care experience. i hope we can talk about a lot of other great promising companies. it proves if you try to put valuations ahead of patients, you're going to get burned. emily: where do you see potential? there are a lot of newer investors getting into the space. you have bee

and absolutely no mention of the company theranos. >> sounds good. a couple people know theranos. let me start with linda. you are the ceo of we are curious. we met four or five years ago at a conference in new york. so, it's great to reconnect here. in a couple of minutes, tell us who you are and how you got where you are. a little bit about what is going on a curious. linda: great. thanks, dave. great to be here. always fun to come to los angeles from up north. how i got here really came from seeing how research was happening in mostly the academic world, where we saw clusters of studies going on, whether it was autism or chronic fatigue. whatever the disease condition, i was first thinking about this over 10 years ago. you would see these little studies being funded by nih, but typically, they were underpowered. and we were not really able to get enough people enrolled in the studies or get big enough grants to fund large enough studies. and a lot of that is what led to the founding of 23 and me, a whole new way of doing genetics research through

we've been covering the turmoil surrounding theranos ceo elizabeth holmes who made headlines from going from billionaire to broke. the palo alto company is appealing federal sanctions on its labs. the company had submitted an improved test for the zika virus, but voluntarily withdrew it today. "wall street journal" quotes sources who say data collection protocols weren't followed. company, show, says it stands behind its test and will resubmit it. >>> facebook wants you to get virtual but admits things it could be a little smoother. it's working on a way to improve the experience. in a story only on nbc bay area, scott budmans, tech reporter, has an exclusive sneak peek. facebook is combining real and virtual and something else you love, basketball. >> reporter: well, good evening, jessica. facebook did set up shop here at san jose's convention center to show ways that virtual reality could be smoother in the future. using a mix of new software and old-fashioned basketball. facebook admits the current v.r. experience can be a little shaky. >> this is the oculus headset. >> reporter: par